For more than forty years, Mr. Meyer has provided strategic, competitive advice to a diverse range of clients from start-ups to emerging growth to universities and research organizations to Fortune 500 companies and investors in all aspects of procurement, counseling and enforcement of intellectual property (“IP”) rights. His work has included strategic development of patent portfolios, technology transactions and related counseling including joint ventures, IP due diligence, validity and product clearance/right to use opinions, patent enforcement programs, license agreements, negotiations, and high stakes patent & trademark litigation, including post-grant proceedings at the US Patent & Trademark Office.
Mr. Meyer represented the first patent owner to successfully defend all challenged claims in an inter partes review. He has also advised clients involved in international enforcement proceedings in Germany, The Hague and the EPO. Mr. Meyer's experience began as a patent examiner in the U.S. Patent & Trademark Office and spans numerous industries and technologies, including, air and water pollution control, automotive, biotechnology including cell sorting and separation, diagnostics and drug development, including neurodegenerative
disease and traumatic brain injury chemical compounds and processes, computer hardware and software, consumer and juvenile products, electronics, e-Commerce/Internet, life sciences, medical devices, including dental, cardiovascular, spine and surgical devices, and microfluidics, pharmaceuticals (Hatch-Waxman ANDA), and telecommunications. He has particular expertise in high profile patent disputes in the biotechnology, computer, medical devices, pharmaceutical, software, and telecommunications fields. A detailed list of specific technologies with which Mr. Meyer has significant experience can be found here.
For the last nine years at Capital IP Law Group (aka Capital Technology Law Group). Mr. Meyer has been helping startups and emerging growth companies bring important medical technologies to market. He currently serves as Chief IP Counsel to BRAINBox Solutions, Inc., a company focused in diagnosis, prognosis, and therapy monitoring of neurogenerative disease and traumatic brain injury.
Before co-founding Capital IP Law Group (aka Capital Technology Law Group), Mr. Meyer helped start and develop IP practices at a number of prestigious law firms, including Morgan Lewis, Townsend & Townsend, and Boies Schiller. A representative sample of his litigated matters appears below:
